{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:12:31Z","timestamp":1789186351399,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST108-2221-E-038-006"],"award-info":[{"award-number":["MOST108-2221-E-038-006"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST106-2314-B-038-036-MY3"],"award-info":[{"award-number":["MOST106-2314-B-038-036-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The association between pancreatitis and acute myocardial infarction or stroke remains incompletely understood. This study aimed to evaluate the long-term risk of acute atherosclerotic cardiovascular disease (ASCVD) in people with acute and chronic pancreatitis. Using research database of Taiwan's National Health Insurance, we identified 2678 patients aged\u2009\u2265\u200920\u00a0years with newly diagnosed pancreatitis in 2000\u20132008. A cohort of 10,825 adults without pancreatitis was selected for comparison, with matching by age and sex. Both cohorts were followed from 2000 to the end of 2013, and incident acute ASCVD was identified during the follow-up period. Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) of acute ASCVD associated with pancreatitis were calculated. Compared with the comparison cohort, the adjusted HR of acute ASCVD were 1.76 (95% CI 1.47\u20132.12) and 3.42 (95% CI 1.69\u20136.94) for people with acute pancreatitis and chronic pancreatitis, respectively. A history of alcohol-related illness (HR 9.49, 95% CI 3.78\u201323.8), liver cirrhosis (HR 7.31, 95% CI 1.81\u201329.5), and diabetes (HR 6.89, 95% CI 2.18\u201321.8) may worsen the risk of acute ASCVD in patients with chronic pancreatitis. Compared with people had no pancreatitis, patients with acute pancreatitis who had alcohol-related illness (HR 4.66, 95% CI 3.24\u20136.70), liver cirrhosis (HR 4.44, 95% CI 3.05\u20136.47), and diabetes (HR 2.61, 95% CI 2.03\u20133.36) were at increased risk of acute ASCVD. However, the cumulative use of metformin was associated with a reduced risk of acute ASCVD in the acute pancreatitis cohort (HR 0.30, 95% CI 0.17\u20130.50). Compared with the control group, patients with acute or chronic pancreatitis were more likely to have an increased risk of acute ASCVD, while the use of metformin reduced the risk of acute ASCVD. Our findings warrant a survey and education on acute ASCVD for patients with acute and chronic pancreatitis.<\/jats:p>","DOI":"10.1038\/s41598-021-99915-4","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T10:09:32Z","timestamp":1634897372000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Risk of acute atherosclerotic cardiovascular disease in patients with acute and chronic pancreatitis"],"prefix":"10.1038","volume":"11","author":[{"given":"Li-Chin","family":"Sung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuen-Chau","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Shun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Chieh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yih-Giun","family":"Cherng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ta-Liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Chang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,22]]},"reference":[{"issue":"10","key":"99915_CR1","doi-asserted-by":"publisher","first-page":"e56-528","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin, E. J. et al. Heart Disease and Stroke Statistics-2019 update: A report from the American Heart Association. Circulation 139(10), e56-528 (2019).","journal-title":"Circulation"},{"issue":"1","key":"99915_CR2","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1177\/2048872612441582","volume":"1","author":"L Badimon","year":"2012","unstructured":"Badimon, L., Padr\u00f3, T. & Vilahur, G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur. Heart J. Acute Cardiovasc. Care 1(1), 60\u201374 (2012).","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"issue":"4","key":"99915_CR3","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","volume":"118","author":"MA Gimbrone Jr","year":"2016","unstructured":"Gimbrone, M. A. Jr. & Garc\u00eda-Carde\u00f1a, G. Endothelial cell dysfunction and the pathobiology of atherosclerosis. Circ. Res. 118(4), 620\u2013636 (2016).","journal-title":"Circ. Res."},{"issue":"4","key":"99915_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jfma.2016.11.013","volume":"116","author":"YH Li","year":"2017","unstructured":"Li, Y. H. et al. 2017 Taiwan lipid guidelines for high risk patients. J. Formos. Med. Assoc. 116(4), 217\u2013248 (2017).","journal-title":"J. Formos. Med. Assoc."},{"issue":"2 Suppl 3","key":"99915_CR5","first-page":"1","volume":"6","author":"PA Banks","year":"2010","unstructured":"Banks, P. A., Conwell, D. L. & Toskes, P. P. The management of acute and chronic pancreatitis. Gastroenterol. Hepatol. 6(2 Suppl 3), 1\u201316 (2010).","journal-title":"Gastroenterol. Hepatol."},{"issue":"3","key":"99915_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41575-018-0087-5","volume":"16","author":"MS Petrov","year":"2019","unstructured":"Petrov, M. S. & Yadav, D. Global epidemiology and holistic prevention of pancreatitis. Nat. Rev. Gastroenterol. Hepatol. 16(3), 175\u2013184 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"5","key":"99915_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.pan.2017.07.189","volume":"17","author":"WS Chung","year":"2017","unstructured":"Chung, W. S. & Lin, C. L. Incidence and risk of acute coronary syndrome in patients with acute pancreatitis: A nationwide cohort study. Pancreatology 17(5), 675\u2013680 (2017).","journal-title":"Pancreatology"},{"issue":"4","key":"99915_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ihj.2013.06.009","volume":"65","author":"A Vasantha Kumar","year":"2013","unstructured":"Vasantha Kumar, A., Mohan Reddy, G. & Anirudh Kumar, A. Acute pancreatitis complicated by acute myocardial infarction\u2014A rare association. Indian Heart J. 65(4), 474\u2013477 (2013).","journal-title":"Indian Heart J."},{"issue":"24","key":"99915_CR9","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1001\/jama.2019.19411","volume":"322","author":"VK Singh","year":"2019","unstructured":"Singh, V. K., Yadav, D. & Garg, P. K. Diagnosis and management of chronic pancreatitis: A review. JAMA 322(24), 2422\u20132434 (2019).","journal-title":"JAMA"},{"issue":"20","key":"99915_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003451","volume":"95","author":"MT Hsu","year":"2016","unstructured":"Hsu, M. T., Lin, C. L. & Chung, W. S. Increased risk of acute coronary syndrome in patients with chronic pancreatitis: A nationwide cohort analysis. Medicine 95(20), e3451 (2016).","journal-title":"Medicine"},{"issue":"15","key":"99915_CR11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003266","volume":"95","author":"TS Wong","year":"2016","unstructured":"Wong, T. S. et al. Chronic pancreatitis correlates with increased risk of cerebrovascular disease: A retrospective population-based cohort study in Taiwan. Medicine 95(15), e3266 (2016).","journal-title":"Medicine"},{"key":"99915_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.atherosclerosis.2020.11.023","volume":"317","author":"YC Huang","year":"2021","unstructured":"Huang, Y. C. et al. The protective effect of statins against pressure ulcers in stroke patients: A propensity-score matched study based on a real-world database. Atherosclerosis 317, 22\u201328 (2021).","journal-title":"Atherosclerosis"},{"issue":"4","key":"99915_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1093\/qjmed\/hcy278","volume":"112","author":"TL Chen","year":"2019","unstructured":"Chen, T. L., Yeh, C. C., Lin, C. S., Shih, C. C. & Liao, C. C. Effects of red yeast rice prescription (LipoCol Forte) on adverse outcomes of surgery. QJM 112(4), 253\u2013259 (2019).","journal-title":"QJM"},{"issue":"2","key":"99915_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001351","volume":"8","author":"CS Lin","year":"2020","unstructured":"Lin, C. S. et al. Outcomes after surgery in patients with diabetes who used metformin: A retrospective cohort study based on a real-world database. BMJ Open Diabetes Res. Care 8(2), e001351 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"99915_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2147\/DMSO.S223833","volume":"13","author":"TL Chen","year":"2020","unstructured":"Chen, T. L. et al. Evaluating risk of incident diabetes between patients who used lovastatin and red yeast rice prescriptions (LipoCol Forte): A retrospective cohort study based on a real-world database. Diabetes Metab. Syndr. Obes. 13, 89\u201398 (2020).","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"5","key":"99915_CR16","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/MOG.0000000000000195","volume":"31","author":"A Habtezion","year":"2015","unstructured":"Habtezion, A. Inflammation in acute and chronic pancreatitis. Curr. Opin. Gastroenterol. 31(5), 395\u2013399 (2015).","journal-title":"Curr. Opin. Gastroenterol."},{"issue":"6","key":"99915_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.cytogfr.2015.04.003","volume":"26","author":"DP Ramji","year":"2015","unstructured":"Ramji, D. P. & Davies, T. S. Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev. 26(6), 673\u2013685 (2015).","journal-title":"Cytokine Growth Factor Rev."},{"issue":"22","key":"99915_CR18","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","volume":"37","author":"D Tousoulis","year":"2016","unstructured":"Tousoulis, D., Oikonomou, E., Economou, E. K., Crea, F. & Kaski, J. C. Inflammatory cytokines in atherosclerosis: Current therapeutic approaches. Eur. Heart J. 37(22), 1723\u20131732 (2016).","journal-title":"Eur. Heart J."},{"issue":"5","key":"99915_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.5114\/aoms.2017.65816","volume":"13","author":"M Pawelczyk","year":"2017","unstructured":"Pawelczyk, M., Kaczorowska, B. & Baj, Z. The impact of hyperglycemia and hyperlipidemia on plasma P-selectin and platelet markers after ischemic stroke. Arch. Med. Sci. 13(5), 1049\u20131056 (2017).","journal-title":"Arch. Med. Sci."},{"issue":"5","key":"99915_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1253\/circj.CJ-19-0239","volume":"83","author":"H Ohmura","year":"2019","unstructured":"Ohmura, H. Triglycerides as residual risk for atherosclerotic cardiovascular disease. Circ. J. 83(5), 969\u2013970 (2019).","journal-title":"Circ. J."},{"issue":"10","key":"99915_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076448","volume":"8","author":"MT Olaiya","year":"2013","unstructured":"Olaiya, M. T., Chiou, H. Y., Jeng, J. S., Lien, L. M. & Hsieh, F. I. Significantly increased risk of cardiovascular disease among patients with gallstone disease: A population-based cohort study. PLoS\u00a0One 8(10), e76448 (2013).","journal-title":"PLoS\u00a0One"},{"issue":"10","key":"99915_CR22","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1161\/ATVBAHA.115.306043","volume":"35","author":"J Lv","year":"2015","unstructured":"Lv, J. et al. Gallstone disease and the risk of ischemic heart disease. Arterioscler. Thromb. Vasc. Biol. 35(10), 2232\u20132237 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"99915_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/hr.2016.109","volume":"40","author":"KJ Yu","year":"2017","unstructured":"Yu, K. J. et al. Gallstone disease is associated with arterial stiffness progression. Hypertens. Res. 40(1), 31\u201334 (2017).","journal-title":"Hypertens. Res."},{"issue":"5","key":"99915_CR24","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.2337\/dc12-0719","volume":"36","author":"J Hong","year":"2013","unstructured":"Hong, J. et al. Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Diabetes Care 36(5), 1304\u20131311 (2013).","journal-title":"Diabetes Care"},{"issue":"4","key":"99915_CR25","doi-asserted-by":"publisher","first-page":"R137","DOI":"10.1530\/EJE-20-0468","volume":"184","author":"MS Petrov","year":"2020","unstructured":"Petrov, M. S. Diagnosis of endocrine disease: Post-pancreatitis diabetes mellitus: Prime time for secondary disease. Eur. J. Endocrinol. 184(4), R137\u2013R149 (2020).","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"99915_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/ajcn\/81.5.1117","volume":"81","author":"D Quilliot","year":"2005","unstructured":"Quilliot, D. et al. Diabetes mellitus worsens antioxidant status in patients with chronic pancreatitis. Am. J. Clin. Nutr. 81(5), 1117\u20131125 (2005).","journal-title":"Am. J. Clin. Nutr."},{"issue":"9","key":"99915_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.lpm.2018.08.009","volume":"47","author":"F Roubille","year":"2018","unstructured":"Roubille, F. et al. Is hypertriglyceridemia atherogenic?. Presse Med. 47(9), 757\u2013763 (2018).","journal-title":"Presse Med."},{"issue":"11","key":"99915_CR28","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019343","volume":"10","author":"S Saadatagah","year":"2021","unstructured":"Saadatagah, S. et al. Coronary heart disease risk associated with primary isolated hypertriglyceridemia; A population-based study. J. Am. Heart Assoc. 10(11), e019343 (2021).","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"99915_CR29","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s12933-019-0860-y","volume":"18","author":"F Luo","year":"2019","unstructured":"Luo, F. et al. Metformin in patients with and without diabetes: A paradigm shift in cardiovascular disease management. Cardiovasc. Diabetol. 18(1), 54 (2019).","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"99915_CR30","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","volume":"119","author":"AR Cameron","year":"2016","unstructured":"Cameron, A. R. et al. Anti-inflammatory effects of metformin irrespective of diabetes status. Circ. Res. 119(5), 652\u2013665 (2016).","journal-title":"Circ. Res."},{"issue":"4","key":"99915_CR31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/MOL.0000000000000532","volume":"29","author":"AJ Jenkins","year":"2018","unstructured":"Jenkins, A. J., Welsh, P. & Petrie, J. R. Metformin, lipids and atherosclerosis prevention. Curr. Opin. Lipidol. 29(4), 346\u2013353 (2018).","journal-title":"Curr. Opin. Lipidol."},{"issue":"9","key":"99915_CR32","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.2337\/dc19-0145","volume":"42","author":"J Cho","year":"2019","unstructured":"Cho, J., Scragg, R., Pandol, S. J., Goodarzi, M. O. & Petrov, M. S. Antidiabetic medications and mortality risk in individuals with pancreatic cancer-related diabetes and postpancreatitis diabetes: A nationwide cohort study. Diabetes Care 42(9), 1675\u20131683 (2019).","journal-title":"Diabetes Care"},{"issue":"6","key":"99915_CR33","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1053\/j.gastro.2015.07.066","volume":"149","author":"SJ Sankaran","year":"2015","unstructured":"Sankaran, S. J. et al. Frequency of progression from acute to chronic pancreatitis and risk factors: A meta-analysis. Gastroenterology 149(6), 1490\u20131500 (2015).","journal-title":"Gastroenterology"},{"issue":"1","key":"99915_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/jgh.14460","volume":"34","author":"D de la Iglesia","year":"2019","unstructured":"de la Iglesia, D. et al. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study. J. Gastroenterol. Hepatol. 34(1), 277\u2013283 (2019).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"99915_CR35","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jcrc.2010.10.013","volume":"26","author":"B Yegneswaran","year":"2011","unstructured":"Yegneswaran, B., Kostis, J. B. & Pitchumoni, C. S. Cardiovascular manifestations of acute pancreatitis. J. Crit. Care 26(2), e11\u2013e18 (2011).","journal-title":"J. Crit. Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99915-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99915-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99915-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:35:39Z","timestamp":1670085339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-99915-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,22]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["99915"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-99915-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,22]]},"assertion":[{"value":"29 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20907"}}